Quantcast
Last updated on April 19, 2014 at 7:35 EDT

Latest Glioma Stories

2012-06-06 21:37:32

Evolution of brain tumor cells under treatment reveal that it is the peripheral tumor cells that need to be targeted An Israeli physicist has developed a theoretical model to simulate the evolution of highly proliferating brain tumor core cells subjected to treatment by alternating radio frequency electric field. The research, by Alexander Iomin from the Israel Institute of Technology Technion in Haifa, is about to be published in EPJ E´. In another model, the author examines the...

2012-05-21 06:25:01

PORTSMOUTH, N.H., May 21, 2012 /PRNewswire/ -- Results of the first randomized controlled trial to compare a novel cancer treatment modality delivering Tumor Treating Fields (TTFields) therapy versus chemotherapy in patients with recurrent glioblastoma (GBM) were published in the European Journal of Cancer (Stupp R. et al., NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: A randomized phase III trial of a novel treatment modality, Eur J...

2012-05-17 12:09:10

-The system doctors use to classify patients' malignant brain tumors is outdated. -Researchers have revised the system to accommodate treatment advances and molecular markers. -The new system will be validated in future clinical trials for malignant gliomas. Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors. The outdated system was...

2012-05-14 06:27:14

PORTSMOUTH, N.H., May 14, 2012 /PRNewswire/ -- In its ongoing effort to help patients, their caregivers and health care professionals easily find detailed information about its NovoTTF(TM) therapy for recurrent glioblastoma, Novocure(TM) today unveiled its U.S.-focused NovoTTF(TM) Therapy Website, found at www.novottftherapy.com. Novocure(TM), a commercial stage private oncology company, manufactures the NovoTTF(TM)-100A,( )a wearable device that delivers tumor treating fields...

2012-05-03 15:47:05

They build "spaghetti models" of cancer progression similar to meteorologists' models for predicting hurricane paths Using mathematical models, researchers in the Integrated Mathematical Oncology (IMO) program at Moffitt Cancer Center are focusing their research on the interaction between the tumor and its microenvironment and the "selective forces" in that microenvironment that play a role in the growth and evolution of cancer. According to Alexander R. A. Anderson, Ph.D., chair of...

2012-05-01 23:03:27

ABTA Recognizes May as Brain Tumor Awareness Month Chicago, IL (PRWEB) May 01, 2012 May is Brain Tumor Awareness Month. In acknowledgement of this time of increased attention and awareness, the American Brain Tumor Association (http://www.abta.org) offers these “Top Ten” facts and statistics about brain tumors: 1)    More than 600,000 people in the United States are currently living with a brain tumor–approximately 209 out of every 100,000 people....

2012-04-18 02:28:30

NEW YORK, April 18, 2012 /PRNewswire/ -- Stemline Therapeutics, Inc. announced that trial results of two clinical studies of direct injection synthetic peptide vaccine, now being developed as SL-701, in both adults and children with advanced brain cancer were selected for late-breaking presentations at the Annual Meeting of the American Association for Cancer Research (AACR) held from March 31 to April 4, 2012 in Chicago, IL. SL-701 is comprised of synthetic peptides corresponding to epitopes...

2012-04-16 05:09:12

(Ivanhoe Newswire)-- A new compound has shown evidence of stopping the spread of tumors while also improving brain cancer treatment in animals, researchers explore how this could this work for humans. Traditional treatment of invasive brain tumors consists of a combination of chemotherapy and radiation, with this treatment few patients survive longer than two years after diagnosis. The reason for this is because the effectiveness of the treatment is limited by the tumor's aggressive...

2012-03-29 02:37:18

Researchers from Emory and the Georgia Institute of Technology have designed a new treatment approach that appears to halt the spread of cancer cells into normal brain tissue in animal models. Treating invasive brain tumors with a combination of chemotherapy and radiation has improved clinical outcomes, but few patients survive longer than two years after diagnosis. The effectiveness of treatment is limited by the tumor's aggressive invasion of healthy brain tissue, which restricts...

2012-03-22 22:45:29

Researchers at Winship Cancer Institute have developed a technique for detecting an "oncometabolite", a chemical produced by some brain tumors´ warped metabolism, via non-invasive imaging. Their approach could allow doctors to know not only that a brain tumor is there, but also that it carries a particular genetic mutation. The researchers´ technique uses magnetic resonance spectroscopy (MRS) to measure a chemical, 2-hydroxyglutarate, which is scarce in normal tissues....